{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:55:20Z","timestamp":1792853720929,"version":"4.5.0"},"reference-count":248,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaad.2017.11.064","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T22:06:47Z","timestamp":1523398007000},"page":"987-1006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Neutrophilic dermatoses"],"prefix":"10.1016","volume":"79","author":[{"given":"Caroline A.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hovik J.","family":"Ashchyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.11.064_bib1","series-title":"Dermatology","first-page":"423","article-title":"Neutrophilic dermatoses","author":"Moschella","year":"2012"},{"key":"10.1016\/j.jaad.2017.11.064_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40257-014-0092-6","article-title":"Neutrophilic dermatoses: an update","volume":"15","author":"Alavi","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11604\/pamj.2015.21.151.6364","article-title":"Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis","volume":"21","author":"Ajili","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jaad.2017.11.064_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"Borregaard","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2017.11.064_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2017.11.064_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2017.11.064_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2017.11.064_bib8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s11427-014-4726-y","article-title":"Dynamic process of phagocytosis and forms of macrophage cell death induced by ingestion of apoptotic neutrophils","volume":"57","author":"Wang","year":"2014","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.jaad.2017.11.064_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0733-8635(02)00006-2","article-title":"Neutrophilic dermatoses","volume":"20","author":"Callen","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.11.064_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/1523-1747.ep12497599","article-title":"IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses","volume":"77","author":"Schr\u00f6der","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.140.5.570","article-title":"Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Beh\u00e7et disease: implication in neutrophil apoptosis dysfunction","volume":"140","author":"Kawakami","year":"2004","journal-title":"Arch Dermatol"},{"issue":"2 suppl 1","key":"10.1016\/j.jaad.2017.11.064_bib13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jaad.2007.08.026","article-title":"Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor","volume":"59","author":"Uhara","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"12 pt 1","key":"10.1016\/j.jaad.2017.11.064_bib14","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7326\/0003-4819-116-12-996","article-title":"The\u00a0Sweet syndrome during therapy with granulocyte colony-stimulating factor","volume":"116","author":"Park","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.20112","article-title":"Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment","volume":"76","author":"Kumar","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2004.12.028","article-title":"Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim","volume":"52","author":"Draper","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1993.tb03083.x","article-title":"Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease","volume":"84","author":"Reuss-Borst","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0190-9622(98)70266-X","article-title":"Sweet's\u00a0syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines?","volume":"39","author":"Giasuddin","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/labinvest.3780064","article-title":"Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts","volume":"80","author":"Oka","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaad.2017.11.064_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","article-title":"Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases","volume":"162","author":"Marzano","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2017.11.064_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/039463201102400218","article-title":"Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses","volume":"24","author":"Marzano","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaad.2017.11.064_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000371879","article-title":"Severe Sweet's syndrome with elevated cutaneous interleukin-1\u03b2 after azathioprine exposure: case report and review of the literature","volume":"230","author":"Imhof","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdermsci.2016.03.005","article-title":"A differential gene expression study: Ptpn6 (SHP-1)-insufficiency leads to neutrophilic dermatosis-like disease (NDLD) in mice","volume":"83","author":"Nesterovitch","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2017.11.064_bib24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ajpath.2017.04.008","article-title":"Tumor necrosis factor-\u03b1 and IL-17A activation induces pericyte-mediated basement membrane remodeling in human neutrophilic dermatoses","volume":"187","author":"Lauridsen","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0560.2006.00654.x","article-title":"Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease","volume":"34","author":"Magro","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/jid.2012.408","article-title":"Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients","volume":"133","author":"Sujobert","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"2 pt 2","key":"10.1016\/j.jaad.2017.11.064_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0190-9622(94)70026-5","article-title":"Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy","volume":"30","author":"Piette","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood-2013-01-478172","article-title":"FLT3 inhibitor-induced neutrophilic dermatosis","volume":"122","author":"Fathi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2017.11.064_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamadermatol.2015.6121","article-title":"FLT3 inhibitor-associated neutrophilic dermatoses","volume":"152","author":"Varadarajan","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib30","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/bjd.15837","article-title":"Dysregulation of inflammatory gene expression in lesional and nonlesional skin of patients with pyoderma gangrenosum","volume":"178","author":"Ortega-Loayza","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2340\/0001555572109111","article-title":"Impairment of some granulocyte functions in Sweet's syndrome","volume":"72","author":"von den Driesch","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(73)93343-6","article-title":"Letter: HL-A5 and Beh\u00e7et's disease","volume":"2","author":"Ohno","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.11.064_bib34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archderm.1988.01670070057019","article-title":"Human leukocyte antigen in Sweet's syndrome and its relationship to Beh\u00e7et's disease","volume":"124","author":"Mizoguchi","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-4632.2009.04422.x","article-title":"Neutrophilic dermatosis of the dorsal hands: a case showing HLA B54, the marker of Sweet's syndrome","volume":"49","author":"Takahama","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit \u03b2 type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.11.064_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000158578","article-title":"Familial Mediterranean fever gene as a possible modifier of Sweet syndrome with chronic myelogenous leukemia","volume":"120","author":"Miyoshi","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMc1412998","article-title":"Sweet's syndrome in patients with MDS and MEFV mutations","volume":"372","author":"Jo","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s004310000500","article-title":"Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature","volume":"159","author":"Beretta-Piccoli","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2017.11.064_bib41","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/302866","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q","volume":"66","author":"Yeon","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2017.11.064_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","article-title":"An acute febrile neutrophilic dermatosis","volume":"76","author":"Sweet","year":"1964","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.1997.tb03796.x","article-title":"Sweet's syndrome and malignancy in the U.K","volume":"137","author":"Bourke","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib45","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1590\/S0365-05962011000400012","article-title":"Sweet's syndrome: study of 73 cases, emphasizing histopathological findings","volume":"86","author":"Rochael","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","article-title":"Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients","volume":"69","author":"Rochet","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/ijd.13232","article-title":"Sweet's syndrome: a retrospective study of 90 cases from a tertiary care center","volume":"55","author":"Amouri","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/ced.12899","article-title":"Sweet syndrome: long-term follow-up of 138 patients","volume":"41","author":"Marcoval","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1203475417690719","article-title":"Sweet syndrome","volume":"21","author":"Casarin Costa","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.11.064_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2017.09.013","article-title":"Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center","volume":"78","author":"Nelson","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3 pt 1","key":"10.1016\/j.jaad.2017.11.064_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.lpm.2006.07.010","volume":"36","author":"Masmoudi","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/pde.12502","article-title":"A review and proposed approach to the neutrophilic dermatoses of childhood","volume":"32","author":"Webb","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaad.2004.07.061","article-title":"Acute febrile neutrophilic dermatosis (Sweet's syndrome) after influenza vaccination","volume":"52","author":"Jovanovi\u0107","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib54","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1365-4632.2006.03005.x","article-title":"Bullous Sweet's syndrome following influenza vaccination in a HIV-infected patient","volume":"45","author":"Tan","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/15569527.2012.759960","article-title":"Sweet's syndrome triggered by pneumococcal vaccination","volume":"32","author":"Pedrosa","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jaad.2017.11.064_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PAP.0000000000000026","article-title":"Systemic lupus erythematosus-associated neutrophilic dermatosis: a review and update","volume":"21","author":"Larson","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib57","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0190-9622(09)80079-0","article-title":"Neutrophilic dermatoses in HIV infection","volume":"31","author":"Berger","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib58","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.transproceed.2009.03.067","article-title":"Sweet syndrome after kidney transplantation","volume":"41","author":"Osband","year":"2009","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jaad.2017.11.064_bib59","first-page":"109","article-title":"Sweet syndrome after autologous stem cell transplant","volume":"14","author":"Alkan","year":"2016","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.jaad.2017.11.064_bib60","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clml.2014.12.009","article-title":"Characteristics of Sweet syndrome in patients with acute myeloid leukemia","volume":"15","author":"Kazmi","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaad.2017.11.064_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.prp.2016.10.008","article-title":"Clinicopathologic, immunophenotyping and cytogenetic analysis of Sweet syndrome in Egyptian patients with acute myeloid leukemia","volume":"213","author":"El-Khalawany","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jaad.2017.11.064_bib62","doi-asserted-by":"crossref","first-page":"e3091","DOI":"10.1097\/MD.0000000000003091","article-title":"Certain autoimmune manifestations are associated with distinctive karyotypes and outcomes in patients with myelodysplastic syndrome: a retrospective cohort study","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2017.11.064_bib63","doi-asserted-by":"crossref","first-page":"e3033","DOI":"10.1097\/MD.0000000000003033","article-title":"Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant: a comparative series of 62 patients","volume":"95","author":"Ghoufi","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jaad.2017.11.064_bib64","first-page":"E20","article-title":"Sweet syndrome induced by oral acetaminophen-codeine following repair of a facial fracture","volume":"100","author":"Bradley","year":"2017","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.064_bib65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/15569527.2011.573833","article-title":"Drug-induced Sweet's syndrome by aceclofenac","volume":"30","author":"Carvalho","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jaad.2017.11.064_bib66","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1067\/mjd.2001.114587","article-title":"Celecoxib-induced Sweet's syndrome","volume":"45","author":"Fye","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib67","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-4632.2009.04098.x","article-title":"Sweet's syndrome: a retrospective study of 42 admitted patients in a Portuguese hospital","volume":"48","author":"Borges da Costa","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib68","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/ijd.12260","article-title":"Simultaneous occurrence of Sweet's syndrome and erythema nodosum possibly associated with sulfasalazine","volume":"53","author":"Yamamoto","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib69","first-page":"176749","article-title":"Drug-induced bullous sweet syndrome with multiple autoimmune features","volume":"2011","author":"Lund","year":"2010","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jaad.2017.11.064_bib70","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-4362.2000.00051.x","article-title":"Diazepam-associated Sweet's syndrome","volume":"39","author":"Guimer\u00e1","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib71","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1592\/phco.27.9.1343","article-title":"Clindamycin-induced Sweet's syndrome","volume":"27","author":"Clark","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2017.11.064_bib72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/DAD.0b013e318165db4a","article-title":"Piperacillin\/tazobactam-induced Sweet syndrome in a patient with chronic lymphocytic leukemia and autoimmune cholangitis","volume":"30","author":"Cholongitas","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib73","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.annder.2011.05.025","article-title":"Sweet's syndrome following oral ciprofloxacin therapy","volume":"138","author":"Baybay","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/qjmed\/hch011","article-title":"Sweet's syndrome associated with norfloxacin in a prostate cancer patient","volume":"97","author":"Aguiar-Bujanda","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2017.11.064_bib75","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.jinf.2005.08.002","article-title":"Ofloxacin induced Sweet's syndrome in a patient with Crohn's disease","volume":"52","author":"Ozdemir","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.jaad.2017.11.064_bib76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3904\/kjim.2003.18.3.187","article-title":"Quinupristin\/dalfopristin-induced Sweet's syndrome","volume":"18","author":"Choi","year":"2003","journal-title":"Korean J Intern Med"},{"issue":"5 pt 2","key":"10.1016\/j.jaad.2017.11.064_bib77","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0190-9622(96)90080-8","article-title":"Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome","volume":"34","author":"Walker","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib78","first-page":"595","article-title":"Doxycycline-induced Sweet's syndrome","volume":"18","author":"Jamet","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"5 pt 2","key":"10.1016\/j.jaad.2017.11.064_bib79","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0190-9622(92)70251-A","article-title":"Minocycline-induced Sweet's syndrome","volume":"27","author":"Thibault","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib80","first-page":"177","article-title":"Nitrofurantoin-associated Sweet's syndrome","volume":"63","author":"Retief","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.064_bib81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/DAD.0000000000000252","article-title":"Ketoconazole-induced Sweet syndrome: a new association","volume":"37","author":"Baquerizo Nole","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.annder.2008.05.024","article-title":"Sweet syndrome induced by chloroquine","volume":"136","author":"El Moutaoui","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib83","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaad.2003.09.033","article-title":"Sweet's syndrome following abacavir therapy","volume":"51","author":"Del Giudice","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib84","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2008.12.011","article-title":"Neutrophilic dermatosis complicating lenalidomide therapy","volume":"61","author":"Thieu","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib85","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CMR.0000000000000017","article-title":"Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy","volume":"23","author":"Pintova","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2017.11.064_bib86","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217606","article-title":"Sweet syndrome: a painful reality","volume":"2016","author":"Khan","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2017.11.064_bib87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1600-0609.2000.9c177.x","article-title":"Sweet's syndrome and Pneumocystis carinii pneumonia: two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia","volume":"65","author":"Chowdhary","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib88","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jaad.2009.04.003","article-title":"Gemcitabine-associated sweet syndrome-like eruption","volume":"65","author":"Martorell-Calatayud","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib89","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1352458510390069","article-title":"Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis","volume":"17","author":"K\u00fcmpfel","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaad.2017.11.064_bib90","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cup.12273","article-title":"Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma","volume":"41","author":"Pattanaprichakul","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib91","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ajh.21510","article-title":"Atypical presentations of Sweet's syndrome in patients with MDS\/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors","volume":"84","author":"Alencar","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib92","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1684\/ejd.2012.1861","article-title":"Histiocytoid Sweet's syndrome potentially related to decitabine in a patient with myelodysplastic syndrome","volume":"22","author":"Park","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib93","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2141.2005.05636.x","article-title":"Bortezomib-induced Sweet syndrome","volume":"131","author":"Knoops","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gynor.2013.01.002","article-title":"Topotecan-induced Sweet's syndrome: a case report","volume":"4","author":"Dickson","year":"2013","journal-title":"Gynecol Oncol Case Rep"},{"key":"10.1016\/j.jaad.2017.11.064_bib95","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/DAD.0000000000000358","article-title":"Neutrophilic dermatosis limited to lipo-lymphedematous skin in a morbidly obese woman on dasatinib therapy","volume":"38","author":"Ainechi","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib96","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archderm.144.3.361","article-title":"Bullous sweet syndrome in a patient with t(9;22)(q34;q11)-positive chronic myeloid leukemia treated with the tyrosine kinase inhibitor nilotinib: interphase cytogenetic detection of BCR-ABL- positive lesional cells","volume":"144","author":"Kaune","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archderm.141.3.368","article-title":"Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia","volume":"141","author":"Ayirookuzhi","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12928-016-0398-9","article-title":"Ticagrelor-induced Sweet syndrome: an unusual dermatologic complication after percutaneous coronary intervention","volume":"32","author":"Ikram","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jaad.2017.11.064_bib99","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1176\/appi.ajp.159.11.1947","article-title":"Sweet's syndrome and polyserositis with clozapine","volume":"159","author":"Schonfeldt-Lecuona","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2017.11.064_bib100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.SMJ.0000157530.63614.9B","article-title":"Sweet syndrome associated with furosemide","volume":"98","author":"Govindarajan","year":"2005","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2017.11.064_bib101","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2133.1995.tb02686.x","article-title":"Drug-induced Sweet's syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine","volume":"133","author":"Gilmour","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0394632015599705","article-title":"Allopurinol-induced Sweet's syndrome","volume":"29","author":"Polimeni","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaad.2017.11.064_bib103","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1046\/j.1365-2133.1999.03186.x","article-title":"Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis","volume":"141","author":"Miller","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-0960.1991.tb00684.x","article-title":"A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive","volume":"32","author":"Tefany","year":"1991","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1783\/147118904322995519","article-title":"Sweet's syndrome and a Mirena intrauterine system","volume":"30","author":"Hamill","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.jaad.2017.11.064_bib106","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-4632.2008.03724.x","article-title":"Drug-induced Sweet's syndrome secondary to\u00a0hepatitis C antiviral therapy","volume":"47","author":"Gheorghe","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib107","article-title":"Sweet syndrome associated with interferon","volume":"21","author":"Rodriguez-Lojo","year":"2014","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2017.11.064_bib108","first-page":"206","article-title":"Bullous Sweet's syndrome and pseudolymphoma precipitated by IL-2 therapy","volume":"85","author":"Rondina","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.064_bib109","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2230.1995.tb01324.x","article-title":"Sweet's syndrome in association with Crohn's disease","volume":"20","author":"Burrows","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/ajd.12185","article-title":"A case of abatacept associated neutrophilic dermatosis and a review of the literature","volume":"55","author":"Tiwari","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.10.2011.4935","article-title":"Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis","volume":"2011","author":"Keidel","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2017.11.064_bib112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ad.2011.04.014","article-title":"Retrospective study of patients diagnosed with Sweet syndrome in the health area of a tertiary hospital in the autonomous community of\u00a0Valencia [in Spanish]","volume":"103","author":"D\u00edaz-Corpas","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2017.11.064_bib113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5826\/dpc.0502a23","article-title":"Proton pump inhibitor-induced Sweet's syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer","volume":"5","author":"Cohen","year":"2015","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.jaad.2017.11.064_bib114","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaad.2006.07.001","article-title":"Sweet's syndrome-like neutrophilic dermatosis resulting from exposure to a radiocontrast agent","volume":"58","author":"Alper","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2230.1994.tb01115.x","article-title":"Sweet's syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia","volume":"19","author":"Cox","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib116","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mpo.10089","article-title":"Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy","volume":"40","author":"Gyorfy","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaad.2017.11.064_bib117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0964-1955(95)00070-4","article-title":"Sweet's syndrome in a patient with oral cancer associated with\u00a0radiotherapy","volume":"32B","author":"van der Meij","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.jaad.2017.11.064_bib118","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000247677","article-title":"Atypical neutrophilic dermatosis on the upper extremity affected by postmastectomy lymphedema: report of 2 cases","volume":"183","author":"Demitsu","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2017.11.064_bib119","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0190-9622(94)70215-2","article-title":"Sweet's syndrome (acute febrile neutrophilic dermatosis)","volume":"31","author":"von den Driesch","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s001050050061","article-title":"Idiopathic pustular and bullous variants of Sweet syndrome [in German]","volume":"45","author":"Tacke","year":"1994","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2017.11.064_bib121","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/2013.jamadermatol.548","article-title":"Giant cellulitis-like Sweet syndrome, a new variant of neutrophilic dermatosis","volume":"149","author":"Surovy","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib122","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2012.02.024","article-title":"Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis","volume":"67","author":"Kroshinsky","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"5 pt 1","key":"10.1016\/j.jaad.2017.11.064_bib123","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1067\/mjd.2000.109286","article-title":"Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited","volume":"43","author":"Galaria","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib124","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.jaad.2013.04.056","article-title":"Targetoid palmoplantar Sweet syndrome as presenting sign of severe Crohn's disease","volume":"69","author":"Smith","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2133.2003.05487.x","article-title":"Photosensitivity in Sweet's syndrome: two cases that were photoinduced and photoaggravated","volume":"149","author":"Belhadjali","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.dad.0000249887.59810.76","article-title":"Acute febrile neutrophilic dermatosis: a histopathologic study of 31 cases with review of literature","volume":"29","author":"Ratzinger","year":"2007","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib127","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-4632.2005.02037.x","article-title":"Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders","volume":"44","author":"del Pozo","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archderm.141.7.834","article-title":"Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes","volume":"141","author":"Requena","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archderm.142.9.1170","article-title":"Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases","volume":"142","author":"Vignon-Pennamen","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaad.2012.12.954","article-title":"Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature","volume":"68","author":"Chan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/cup.12921","article-title":"Cryptococcoid Sweet's syndrome: two reports of Sweet's syndrome mimicking cutaneous cryptococcosis","volume":"44","author":"Wilson","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib132","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-4362.1994.tb04045.x","article-title":"Sweet's syndrome: clinicopathologic study of eleven cases","volume":"33","author":"Chan","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib133","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2133.2006.07677.x","article-title":"Sweet's syndrome: a spectrum of unusual clinical presentations and associations","volume":"156","author":"Neoh","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib134","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2014.01.874","article-title":"Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization","volume":"70","author":"Chavan","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1684\/ejd.2015.2586","article-title":"Histiocytoid Sweet's syndrome: a localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease","volume":"25","author":"Magro","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib136","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jamadermatol.2016.6092","article-title":"Clinicopathologic, immunohistochemical, and molecular features of histiocytoid Sweet syndrome","volume":"153","author":"Alegr\u00eda-Landa","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib137","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000357729","article-title":"Sight-threatening ocular manifestations of acute febrile neutrophilic dermatosis (Sweet's syndrome)","volume":"228","author":"Baartman","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib138","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2169\/internalmedicine.54.2755","article-title":"Multi-organ involvement of Sweet's syndrome: a case report and literature review","volume":"54","author":"Li","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib139","first-page":"CS53","article-title":"Upper-airway obstruction instigated by Sweet's syndrome","volume":"13","author":"Bouw","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaad.2017.11.064_bib140","first-page":"578","article-title":"Sweet's syndrome with subacute intestinal obstruction","volume":"58","author":"Somayajulu","year":"2010","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jaad.2017.11.064_bib141","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/0378-6323.129424","article-title":"Multiple cutaneous nodules in a patient with rheumatoid arthritis","volume":"80","author":"Chen","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2017.11.064_bib142","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/DAD.0b013e3181ce5933","article-title":"A case of sweet syndrome with spleen and lymph node involvement preceded by parvovirus B19 infection, and a review of the literature on extracutaneous sweet syndrome","volume":"32","author":"Fortna","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib143","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1111\/ijd.13287","article-title":"Neuro-Sweet's disease","volume":"55","author":"Kitamura","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib144","first-page":"167","article-title":"Diagnostic criteria for Sweet's syndrome","volume":"37","author":"Su","year":"1986","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.064_bib145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00128071-200203020-00005","article-title":"Sweet's syndrome: a review of current treatment options","volume":"3","author":"Cohen","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib146","first-page":"125","article-title":"The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome","volume":"44","author":"Case","year":"1989","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.064_bib147","first-page":"814","article-title":"Concurrent Sweet's syndrome and erythema nodosum: a report, world literature review and mechanism of pathogenesis","volume":"19","author":"Cohen","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib148","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/1097-0142(19931101)72:9<2723::AID-CNCR2820720933>3.0.CO;2-F","article-title":"Sweet syndrome in patients with solid tumors","volume":"72","author":"Cohen","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2017.11.064_bib149","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1981.tb00785.x","article-title":"Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with colchicine","volume":"105","author":"Suehisa","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2133.1999.02747.x","article-title":"Colchicine for Sweet's syndrome. A study of 20 cases","volume":"140","author":"Maillard","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib151","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1067\/mjd.2002.121028","article-title":"Long-term suppression of chronic Sweet's syndrome with colchicine","volume":"47","author":"Ritter","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00325481.1982.11715956","article-title":"Sweet's syndrome: report of two atypical cases","volume":"71","author":"Schiff","year":"1982","journal-title":"Postgrad Med"},{"issue":"2 suppl 1","key":"10.1016\/j.jaad.2017.11.064_bib153","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jaad.2008.03.044","article-title":"Dapsone-responsive histiocytoid Sweet's syndrome associated with Crohn's disease","volume":"59","author":"Spencer","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib154","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-4632.2008.03648.x","article-title":"HIV-seropositive patient with Sweet's syndrome and nodular scleritis, showing dramatic response after adding dapsone to systemic corticosteroid therapy","volume":"47","author":"Inamadar","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jamadermatol.2013.7814","article-title":"Treatment of giant cellulitis-like Sweet syndrome with dapsone","volume":"150","author":"Koketsu","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib156","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000250516","article-title":"Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with potassium iodide","volume":"160","author":"Horio","year":"1980","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2017.11.064_bib157","first-page":"1609","article-title":"Reactive neutrophilic dermatoses associated with nontuberculous mycobacterial infection in adult-onset immunodeficiency syndrome responded well to acitretin: four cases report","volume":"96","author":"Chiewchanvit","year":"2013","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jaad.2017.11.064_bib158","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/ard.2006.068254","article-title":"Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome","volume":"67","author":"Delluc","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.064_bib159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000326112","article-title":"Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret\u00ae) in a case of refractory Sweet's syndrome","volume":"222","author":"Kluger","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000204674","article-title":"Neutrophilic pustulosis associated with chronic myeloid leukemia: a special form of Sweet's syndrome. Report of two cases","volume":"88","author":"Feliu","year":"1992","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib161","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2133.2002.04701.x","article-title":"Lymphocytic infiltrates as a presenting feature of Sweet's syndrome with myelodysplasia and response to cyclophosphamide","volume":"146","author":"Evans","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib162","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.crohns.2011.07.014","article-title":"Cyclophosphamide therapy in Sweet's syndrome complicating refractory Crohn's disease\u2014efficacy and mechanism of action","volume":"5","author":"Meinhardt","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaad.2017.11.064_bib163","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb14823.x","article-title":"Sweet's syndrome responding to cyclosporin","volume":"127","author":"Bourke","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib164","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/1346-8138.12469","article-title":"Use of cyclosporin A for successful management of steroid-resistant Sweet's syndrome patient with possible myelodysplastic syndrome","volume":"41","author":"Yasuda","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib165","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2133.1993.tb00242.x","article-title":"Successful treatment of Sweet's syndrome with doxycycline","volume":"128","author":"Joshi","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib166","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jfma.2016.12.001","article-title":"A case of Sweet syndrome successfully treated by anti-inflammatory property of doxycycline","volume":"116","author":"Liaw","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jaad.2017.11.064_bib167","first-page":"201","article-title":"Treatment of Sweet's syndrome (active febrile neutrophilic dermatosis) with indomethacin","volume":"4","author":"Hoffman","year":"1977","journal-title":"J Rheumatol"},{"issue":"3 pt 1","key":"10.1016\/j.jaad.2017.11.064_bib168","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0190-9622(97)80222-8","article-title":"Indomethacin treatment of eighteen patients with Sweet's syndrome","volume":"36","author":"Jeanfils","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib169","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000246669","article-title":"Sweet's syndrome with myelofibrosis and leukemia: partial response to interferon","volume":"190","author":"Brodkin","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1525-1470.2005.00133.x","article-title":"Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulin","volume":"22","author":"Haliasos","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib171","doi-asserted-by":"crossref","first-page":"328316","DOI":"10.1155\/2010\/328316","article-title":"Sweet Syndrome due to myelodysplastic syndrome: possible therapeutic role of intravenous immunoglobulin in addition to standard treatment","volume":"2010","author":"Gill","year":"2010","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jaad.2017.11.064_bib172","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JCO.2011.40.3212","article-title":"Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin","volume":"32","author":"Calixto","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2017.11.064_bib173","first-page":"440","article-title":"Successful treatment of an essential thrombocythemia patient complicated by Sweet's syndrome with combination of chemotherapy and lenalidomide","volume":"55","author":"Yamada","year":"2014","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jaad.2017.11.064_bib174","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdcr.2015.03.002","article-title":"Refractory Sweet's syndrome successfully treated with rituximab","volume":"1","author":"Seminario-Vidal","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2017.11.064_bib175","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3892\/mco.2015.715","article-title":"Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: a case report","volume":"4","author":"Hashemi","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jaad.2017.11.064_bib176","first-page":"1","article-title":"Chronic, recurrent neutrophilic dermatosis: a case report","volume":"16","author":"Vij","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2017.11.064_bib177","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/PL00002176","article-title":"Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus [in German]","volume":"96","author":"Fellermann","year":"2001","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.jaad.2017.11.064_bib178","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamadermatol.2016.0503","article-title":"Refractory subcutaneous Sweet syndrome treated with adalimumab","volume":"152","author":"Agarwal","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib179","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.rhu.0000147053.60795.46","article-title":"Refractory sweet syndrome with autoimmune organizing pneumonia treated with monoclonal antibodies to tumor necrosis factor","volume":"10","author":"Karamlou","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib180","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3899\/jrheum.080698","article-title":"Etanercept treatment in Sweet's syndrome with inflammatory arthritis","volume":"36","author":"Ambrose","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib181","first-page":"295","article-title":"Crohn's disease associated with Sweet's syndrome and Sj\u00f6gren's syndrome treated with infliximab","volume":"26","author":"Vanbiervliet","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jaad.2017.11.064_bib182","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.62.1.81","article-title":"Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab","volume":"62","author":"Matzkies","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.064_bib183","first-page":"145","article-title":"Crohn's disease associated with Sweet's syndrome and Sj\u00f6gren's syndrome treated with infliximab","volume":"12","author":"Foster","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaad.2017.11.064_bib184","first-page":"376","article-title":"Regression of Sweet's syndrome associated with Crohn's disease after anti-tumour necrosis factor therapy","volume":"68","author":"Rahier","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jaad.2017.11.064_bib185","first-page":"253","article-title":"Acute febrile neutrophilic dermatosis (Sweet's syndrome). Four case reports","volume":"53","author":"Saxe","year":"1978","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jaad.2017.11.064_bib186","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1744-9987.12113","article-title":"Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy","volume":"17","author":"Sakanoue","year":"2013","journal-title":"Ther Apher Dial"},{"issue":"2 suppl 1","key":"10.1016\/j.jaad.2017.11.064_bib187","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.jaad.2004.12.041","article-title":"Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia","volume":"53","author":"Browning","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"3 suppl 2","key":"10.1016\/j.jaad.2017.11.064_bib188","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jaad.2005.11.1089","article-title":"Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept","volume":"54","author":"Yamauchi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib189","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/2229-5178.137782","article-title":"Disseminated nocardiosis in a patient on infliximab and methylprednisolone for treatment-resistant Sweet's syndrome","volume":"5","author":"Drone","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2017.11.064_bib190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0738-081X(99)00123-6","article-title":"Neutrophilic eccrine hidradenitis","volume":"18","author":"Bachmeyer","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib191","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/j.leukres.2009.11.026","article-title":"Neutrophilic eccrine hidradenitis associated with decitabine","volume":"34","author":"Ng","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2017.11.064_bib192","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/bjd.15259","article-title":"Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event","volume":"176","author":"Herms","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib193","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/15569527.2011.627077","article-title":"Neutrophilic eccrine hidradenitis induced by cetuximab","volume":"31","author":"Turan","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jaad.2017.11.064_bib194","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.leukres.2004.05.015","article-title":"Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy","volume":"29","author":"Dib","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2017.11.064_bib195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0560.2012.01894.x","article-title":"Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists","volume":"39","author":"Hawryluk","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib196","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jdv.12380","article-title":"Neutrophilic eccrine hidradenitis in a patient with Crohn's disease and azathioprine hypersensitivity syndrome","volume":"28","author":"Garc\u00eda-Mart\u00edn","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib197","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0253-7613.106445","article-title":"Neutrophilic eccrine hidradenitis: a new culprit-carbamazepine","volume":"45","author":"Bhanu","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2017.11.064_bib198","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-3083.2003.00669.x","article-title":"Neutrophilic eccrine hidradenitis heralding the onset of chronic myelogenous leukaemia","volume":"17","author":"G\u00f3mez V\u00e1zquez","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib199","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000090664","article-title":"A case of neutrophilic eccrine hidradenitis associated with streptococcal infectious endocarditis","volume":"212","author":"Takai","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib200","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jaad.2005.01.009","article-title":"Childhood neutrophilic eccrine hidradenitis: a clinicopathologic and immunohistochemical study of 10 patients","volume":"52","author":"Shih","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib201","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archderm.1982.01650160053024","article-title":"Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy","volume":"118","author":"Harrist","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0560.1994.tb00702.x","article-title":"Idiopathic plantar hidradenitis: a neutrophilic eccrine hidradenitis occurring primarily in children","volume":"21","author":"Stahr","year":"1994","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2017.11.064_bib203","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ad.2013.04.016","article-title":"Infectious eccrine hidradenitis: a report of 3 cases and a review of the literature","volume":"105","author":"Bassas-Vila","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2017.11.064_bib204","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2133.1992.tb14854.x","article-title":"Recurrent neutrophilic eccrine hidradenitis","volume":"127","author":"Bernstein","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib205","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archderm.1986.01660190087022","article-title":"Neutrophilic eccrine hidradenitis associated with Hodgkin's disease and chemotherapy. A case report","volume":"122","author":"Beutner","year":"1986","journal-title":"Arch Dermatol"},{"issue":"5 pt 2","key":"10.1016\/j.jaad.2017.11.064_bib206","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0190-9622(96)90092-4","article-title":"Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis","volume":"35","author":"Shear","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib207","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Beh\u00e7et's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib208","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Beh\u00e7et's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib209","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib210","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2165\/11641370-000000000-00000","article-title":"Beh\u00e7et's syndrome","volume":"72","author":"Dalvi","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.11.064_bib211","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3349\/ymj.2007.48.4.573","article-title":"Mucocutaneous lesions of Beh\u00e7et's disease","volume":"48","author":"Alpsoy","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaad.2017.11.064_bib212","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-4632.2006.02832.x","article-title":"Vascular involvement in Beh\u00e7et's disease: a retrospective analysis of 2319 cases","volume":"45","author":"Sarica-Kucukoglu","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib213","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1346-8138.1990.tb01653.x","article-title":"Histopathologic study of cutaneous lesions in Beh\u00e7et's syndrome","volume":"17","author":"Chun","year":"1990","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib214","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.11.064_bib215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et's Disease (ITR-ICBD)","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.064_bib216","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2012.156","article-title":"Differential diagnosis and management of Beh\u00e7et syndrome","volume":"9","author":"Ambrose","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib217","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(85)90547-9","article-title":"Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Beh\u00e7et's disease","volume":"79","author":"Firestein","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib218","first-page":"CD001084","article-title":"Pharmacotherapy for Beh\u00e7et's syndrome","volume":"2","author":"Saenz","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.11.064_bib219","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.064_bib220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000182257","article-title":"Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Beh\u00e7et's disease","volume":"218","author":"K\u00f6se","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib221","first-page":"24","article-title":"General manifestations of Beh\u00e7et's syndrome and the success of CO2-laser as treatment for oral lesions: a review of the literature and case presentation","volume":"58","author":"Demetriades","year":"2009","journal-title":"J Mass Dent Soc"},{"key":"10.1016\/j.jaad.2017.11.064_bib222","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1756-185X.2010.01531.x","article-title":"Pimecrolimus versus placebo in genital aphthous ulcers of Beh\u00e7et's disease: a randomized double-blind controlled trial","volume":"13","author":"Chams-Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.064_bib223","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib224","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2230.2011.04169.x","article-title":"Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience","volume":"37","author":"Cheng","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib225","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/annrheumdis-2014-205571","article-title":"Pegylated interferon-\u03b1-2b reduces corticosteroid requirement in patients with Beh\u00e7et's disease with upregulation of circulating regulatory T cells and reduction of Th17","volume":"74","author":"Lightman","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4 suppl 67","key":"10.1016\/j.jaad.2017.11.064_bib226","first-page":"S54","article-title":"Efficacy of adalimumab in patients with Beh\u00e7et's disease unsuccessfully treated with\u00a0infliximab","volume":"29","author":"Olivieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib227","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/rheumatology\/kes130","article-title":"Adalimumab for the treatment of Beh\u00e7et's disease: experience in 19 patients","volume":"51","author":"Perra","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2017.11.064_bib228","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et's disease: multicenter study of 124 patients","volume":"62","author":"Vallet","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaad.2017.11.064_bib229","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-016-3417-4","article-title":"Adalimumab effectiveness in Beh\u00e7et's disease: short and long-term data from a multicenter retrospective observational study","volume":"36","author":"Vitale","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib230","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/039463200902200235","article-title":"Safety and efficacy of etanercept in children with juvenile-onset Beh\u00e7ets disease","volume":"22","author":"Cantarini","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaad.2017.11.064_bib231","first-page":"185","article-title":"Combination therapy with infliximab and methotrexate in recalcitrant mucocutaneous Beh\u00e7et disease","volume":"89","author":"Chan","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.064_bib232","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjoto.2014.04.014","article-title":"Infliximab for refractory oral ulcers","volume":"35","author":"Ryu","year":"2014","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaad.2017.11.064_bib233","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.141344","article-title":"Alemtuzumab as remission induction therapy in Beh\u00e7et disease: a 20-year experience","volume":"42","author":"Mohammad","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib234","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-013-2443-8","article-title":"Anakinra treatment in drug-resistant Beh\u00e7et's disease: a case series","volume":"34","author":"Cantarini","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib235","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-015-3004-0","article-title":"Efficacy and safety profile of anti-interleukin-1 treatment in Beh\u00e7et's disease: a multicenter retrospective study","volume":"35","author":"Emmi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib236","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u00e7et's syndrome \u2013 a phase 2, placebo-controlled study","volume":"16","author":"Hatemi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.11.064_bib237","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/ijd.12144","article-title":"Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Beh\u00e7et's disease","volume":"52","author":"Mumcu","year":"2013","journal-title":"Int J Dermatol"},{"issue":"3 suppl 72","key":"10.1016\/j.jaad.2017.11.064_bib238","first-page":"S115","article-title":"Successful use of canakinumab in a patient with resistant Beh\u00e7et's disease","volume":"30","author":"Cantarini","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib239","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000358125","article-title":"Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Beh\u00e7et's disease: a case series","volume":"228","author":"Vitale","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.064_bib240","first-page":"e68","article-title":"The therapeutic role of isotretinoin in the management of Beh\u00e7et's disease: a single-blinded, controlled therapeutic study","volume":"12","author":"Sharquie","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib241","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2012-202392","article-title":"Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa","volume":"72","author":"Baerveldt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.064_bib242","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2017.05.002","article-title":"Ustekinumab for Beh\u00e7et's disease","volume":"82","author":"Mirouse","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaad.2017.11.064_bib243","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/1346-8138.12296","article-title":"Granulocyte and monocyte adsorption apheresis for Beh\u00e7et's disease in a pregnant woman","volume":"40","author":"Higashi","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib244","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.anai.2012.05.014","article-title":"Optimal use of ivig in a patient with Beh\u00e7et syndrome and common variable immunodeficiency","volume":"109","author":"Shutty","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2017.11.064_bib245","first-page":"238","article-title":"Efficacy and safety of intravenous immunoglobulin treatment in refractory Beh\u00e7et's disease with different organ involvement: a case series","volume":"18","author":"Cantarini","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jaad.2017.11.064_bib246","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-4632.2010.04505.x","article-title":"Mycophenolate sodium in the treatment of mucocutaneous Beh\u00e7et's diseases","volume":"50","author":"K\u00f6se","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib247","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10067-013-2433-x","article-title":"Improved clinical control of a challenging case of Beh\u00e7et's disease with rituximab therapy","volume":"33","author":"Zhao","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.064_bib248","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.semarthrit.2015.11.012","article-title":"Tocilizumab in severe and refractory Beh\u00e7et's disease: four cases and literature review","volume":"45","author":"Deroux","year":"2016","journal-title":"Semin Arthritis Rheum"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218305048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218305048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:25Z","timestamp":1759272565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218305048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":248,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0190962218305048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.11.064","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic dermatoses","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.11.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(18)32768-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}